Lantern Pharma Inc. Increase (Decrease) in Prepaid Expense
Lantern Pharma Inc. (LTRN) reported Increase (Decrease) in Prepaid Expense of $984.46 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2022-03-10
- Lantern Pharma Inc. increase (decrease) in prepaid expense for the quarter ending 2021-12-31 was $490.82K.
- Lantern Pharma Inc. increase (decrease) in prepaid expense for the quarter ending 2021-09-30 was $323.77K, a 79.79% decline year-over-year.
- Lantern Pharma Inc. increase (decrease) in prepaid expense for the quarter ending 2021-06-30 was $66.80K.
- Lantern Pharma Inc. increase (decrease) in prepaid expense for the quarter ending 2021-03-31 was $103.08K, a 21.53% decline year-over-year.
- Lantern Pharma Inc. increase (decrease) in prepaid expense for fiscal 2021 was $984.46K, a 2.23% decline from fiscal 2020.
- Lantern Pharma Inc. increase (decrease) in prepaid expense for fiscal 2020 was $1.01M, a 127679.44% increase from fiscal 2019.
- Lantern Pharma Inc. increase (decrease) in prepaid expense for fiscal 2019 was $788.00.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $490.82K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $814.58K derived: sum of 2 quarters · filed 2022-03-10 | $881.38K derived: sum of 3 quarters · filed 2022-03-10 | $984.46K 10-K · filed 2022-03-10 |
| 2021-09-30 | $323.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $390.57K derived: sum of 2 quarters · filed 2021-11-01 | $493.65K 10-Q · filed 2021-11-01 | -$171.47K derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-06-30 | $66.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $169.88K 10-Q · filed 2021-07-29 | -$495.23K derived: sum of 3 quarters · filed 2022-03-10 | $1.11M derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-03-31 | $103.08K 10-Q · filed 2021-05-03 | -$562.03K derived: sum of 2 quarters · filed 2022-03-10 | $1.04M derived: sum of 3 quarters · filed 2022-03-10 | $978.63K derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-12-31 | -$665.11K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $936.91K derived: sum of 2 quarters · filed 2022-03-10 | $875.54K derived: sum of 3 quarters · filed 2022-03-10 | $1.01M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $1.54M derived: sum of 2 quarters · filed 2021-11-01 | $1.67M 10-Q · filed 2021-11-01 | $1.65M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | -$61.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $69.99K 10-Q · filed 2021-07-29 | $44.83K derived: sum of 3 quarters · filed 2021-07-29 | $38.41K derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $131.36K 10-Q · filed 2021-05-03 | $106.19K derived: sum of 2 quarters · filed 2021-05-03 | $99.78K derived: sum of 3 quarters · filed 2021-05-03 | |
| 2019-12-31 | -$25.16K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$31.57K derived: sum of 2 quarters · filed 2021-03-10 | $788.00 10-K · filed 2021-03-10 | |
| 2019-09-30 | -$6.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $25.95K 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $32.36K 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |